pharmacopeia

Drug Resistance

67 drugs18,271 FAERS reportsMedDRA PT
GET
/api/v1/reaction/drug-resistance
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D004351

Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.

Source: U.S. National Library of Medicine — MeSH (Drug Resistance)

Drugs reporting Drug Resistance (67)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Adefovir27522%
  2. 2Tecovirimat1918%
  3. 3Gefitinib1,24914%
  4. 4Foscarnet50113%
  5. 5Streptomycin14513%
  6. 6Nevirapine1,02812%
  7. 7Tafenoquine811%
  8. 8Piperonyl Butoxide111%
  9. 9Pyrethrum Extract111%
  10. 10Cidofovir14811%
  11. 11Cefiderocol309.9%
  12. 12Peramivir159.7%
  13. 13Interleukin-1219.1%
  14. 14Brincidofovir128.8%
  15. 15Gentian Violet47.8%
  16. 16Rimantadine27.7%
  17. 17Maribavir1767.6%
  18. 18Avibactam117.0%
  19. 19Ensartinib26.9%
  20. 20Ganciclovir7206.7%
  21. 21Efavirenz7356.6%
  22. 22Cefoxitin896.5%
  23. 23Etravirine2585.9%
  24. 24Rifabutin1605.6%
  25. 25Cycloserine1175.3%
  26. 26Fosamprenavir64.6%
  27. 27Lamivudine2,0404.3%
  28. 28Doravirine434.2%
  29. 29Vaborbactam24.1%
  30. 30Zidovudine7964.0%
  31. 31Hepatitis B Immune Globulin23.9%
  32. 32Pyrazinamide3533.8%
  33. 33Erlotinib4733.8%
  34. 34Anidulafungin583.7%
  35. 35Valganciclovir6583.6%
  36. 36Osimertinib1,0823.6%
  37. 37Tigecycline2123.5%
  38. 38Entecavir4033.5%
  39. 39Maraviroc793.5%
  40. 40Amikacin6163.4%
  41. 41Pentobarbital33.3%
  42. 42Rifampin4533.2%
  43. 43Letermovir953.2%
  44. 44Griseofulvin93.2%
  45. 45Ceftolozane303.1%
  46. 46Artemether63.1%
  47. 47Lumefantrine63.1%
  48. 48Rufinamide773.0%
  49. 49Imatinib1,2092.9%
  50. 50Isoniazid4542.9%
  51. 51Dactinomycin612.8%
  52. 52Miltefosine102.7%
  53. 53Flucytosine352.6%
  54. 54Linezolid7462.6%
  55. 55Rezafungin22.6%
  56. 56Oxacillin282.5%
  57. 57Meropenem7902.5%
  58. 58Ceftazidime1822.4%
  59. 59Terbinafine2042.4%
  60. 60Relebactam22.2%
  61. 61Larotrectinib192.2%
  62. 62Caspofungin1002.2%
  63. 63Eptifibatide152.0%
  64. 64Voriconazole5791.9%
  65. 65Bivalirudin171.8%
  66. 66Pretomanid111.7%
  67. 67Dasatinib5981.6%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Drug Resistance as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients